(Q42539090)

1 November 2017

L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. (English)

1 reference

1 November 2017

1 reference

1 reference

1 reference

3

Björklund A

1 reference

1 November 2017

Cenci MA

1

1 reference

PubMed ID

9767399

1 November 2017

Lee CS

series ordinal

2

1 reference

PubMed ID

9767399

1 November 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

European Journal of Neuroscience

1 November 2017

1 reference

1 November 2017

10

1 reference

1 November 2017

8

1 reference

1 November 2017

2694-2706

1 reference

Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats

1 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

The functional anatomy of basal ganglia disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

Naloxone reverses L-dopa induced overstimulation effects in a Parkinson's disease animal model analogue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

Glutamic acid decarboxylase gene expression in the dopamine-denervated striatum: effects of intrastriatal fetal nigral transplants or chronic apomorphine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

Enhancement of the behavioral response to apomorphine administration following repeated treatment in the 6-hydroxydopamine-lesioned rat is temporally correlated with a rise in striatal preproenkephalin-B, but not preproenkephalin-A, gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

Influence of dopamine on GABA release in striatum: evidence for D1-D2 interactions and non-synaptic influences

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

Dopaminergic regulation of glutamic acid decarboxylase mRNA expression and GABA release in the striatum: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

Functional implications of kappa opioid receptor-mediated modulation of glutamate transmission in the output regions of the basal ganglia in rodent and primate models of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

Mesencephalic grafts partially restore normal nigral dynorphin levels in 6-hydroxydopamine-lesioned rats treated chronically with L-dihydroxyphenylalanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

Ventrolateral striatal dopamine depletions impair feeding and food handling in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

Levodopa-induced dyskinesias in parkinsonian monkeys: relationship to extent of nigrostriatal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

Messenger RNAs encoding glutamate-decarboxylases are differentially affected by nigrostriatal lesions in subpopulations of striatal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

Dynorphin levels in parkinsonian patients: Leu5-enkephalin production from either proenkephalin A or prodynorphin in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.T01-1-00285.X

10.1046/J.1460-9568.1998.T01-1-00285.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference

PubMed ID

9767399